The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska J,
de Winter R,
Hamm C,
Steg P,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study
Lee WLS,
Tam FCC,
Chan KKW,
Lam S,
Kong S-L,
Shea CP,
Wong MKL,
Wong AYT,
Yung ASY,
Zhang L-W,
Lam Y-M,
Mintz G,
Costa R,
Stoll H,
Maehara A
September 20, 2018 | 10.4244/EIJ-D-18-00061
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber C,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning AP,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley S,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II
Vaina S,
Voudris V,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Schuijer M,
Macours N,
Stoll H,
Cokkinos D,
Stefanadis C,
Serruys P
January 20, 2009
Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
Serruys P,
Daemen J,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Dawkins K,
Vranckx P,
Bressers M,
van Domburg R,
Schuijer M,
Wittebols K,
Pieters M,
Stoll H
January 20, 2008
Latest news
AHEAD OF PRINT
In vitro effect of intravascular lithotripsy on the polymer of a drug-eluting stent
FREE ARTICLE - Alexandru Achim et al
July 1, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022
NEW ISSUE
A TAVI in Bicuspid Anatomies; TMVI; Bailout-TEER or Medical Therapy; DRT following LAAO; Cost-Effectiveness of FFR-Guided MVD Revascularisation in STEMI and more
June 24, 2022
AHEAD OF PRINT
Bioprosthetic dysfunction of the LOTUS valve
FREE ARTICLE - Rutger-Jan Nuis et al
June 17, 2022
AHEAD OF PRINT
Coronary access after ViV-TAVI with ACURATE neo2
FREE ARTICLE - Arif A. Khokhar et al.
June 16, 2022
AHEAD OF PRINT
Prognostic value of structural and functional microvascular dysfunction
FREE ARTICLE - Coen K.M. Boerhout et al
June 13, 2022
AHEAD OF PRINT
TAVR with the ACURATE neo2
FREE ARTICLE - Andrea Scotti et al
June 8, 2022